Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev












Signal Accounts for Members
All Signal Accounts
All Contests



Euro Zone Industrial Output YoY (Oct)A:--
F: --
P: --
Euro Zone Industrial Output MoM (Oct)A:--
F: --
P: --
Canada National Economic Confidence IndexA:--
F: --
P: --
Canada New Housing Starts (Nov)A:--
F: --
U.S. NY Fed Manufacturing Employment Index (Dec)A:--
F: --
P: --
U.S. NY Fed Manufacturing Index (Dec)A:--
F: --
P: --
Canada Core CPI YoY (Nov)A:--
F: --
P: --
Canada Manufacturing Unfilled Orders MoM (Oct)A:--
F: --
P: --
U.S. NY Fed Manufacturing Prices Received Index (Dec)A:--
F: --
P: --
U.S. NY Fed Manufacturing New Orders Index (Dec)A:--
F: --
P: --
Canada Manufacturing New Orders MoM (Oct)A:--
F: --
P: --
Canada Core CPI MoM (Nov)A:--
F: --
P: --
Canada Trimmed CPI YoY (SA) (Nov)A:--
F: --
P: --
Canada Manufacturing Inventory MoM (Oct)A:--
F: --
P: --
Canada CPI YoY (Nov)A:--
F: --
P: --
Canada CPI MoM (Nov)A:--
F: --
P: --
Canada CPI YoY (SA) (Nov)A:--
F: --
P: --
Canada Core CPI MoM (SA) (Nov)A:--
F: --
P: --
Canada CPI MoM (SA) (Nov)A:--
F: --
P: --
Federal Reserve Board Governor Milan delivered a speech
U.S. NAHB Housing Market Index (Dec)A:--
F: --
P: --
Australia Composite PMI Prelim (Dec)A:--
F: --
P: --
Australia Services PMI Prelim (Dec)A:--
F: --
P: --
Australia Manufacturing PMI Prelim (Dec)A:--
F: --
P: --
Japan Manufacturing PMI Prelim (SA) (Dec)A:--
F: --
P: --
U.K. 3-Month ILO Employment Change (Oct)A:--
F: --
P: --
U.K. Unemployment Claimant Count (Nov)A:--
F: --
U.K. Unemployment Rate (Nov)A:--
F: --
P: --
U.K. 3-Month ILO Unemployment Rate (Oct)A:--
F: --
P: --
U.K. Average Weekly Earnings (3-Month Average, Including Bonuses) YoY (Oct)A:--
F: --
U.K. Average Weekly Earnings (3-Month Average, Excluding Bonuses) YoY (Oct)A:--
F: --
France Services PMI Prelim (Dec)--
F: --
P: --
France Composite PMI Prelim (SA) (Dec)--
F: --
P: --
France Manufacturing PMI Prelim (Dec)--
F: --
P: --
Germany Services PMI Prelim (SA) (Dec)--
F: --
P: --
Germany Manufacturing PMI Prelim (SA) (Dec)--
F: --
P: --
Germany Composite PMI Prelim (SA) (Dec)--
F: --
P: --
Euro Zone Composite PMI Prelim (SA) (Dec)--
F: --
P: --
Euro Zone Services PMI Prelim (SA) (Dec)--
F: --
P: --
Euro Zone Manufacturing PMI Prelim (SA) (Dec)--
F: --
P: --
U.K. Services PMI Prelim (Dec)--
F: --
P: --
U.K. Manufacturing PMI Prelim (Dec)--
F: --
P: --
U.K. Composite PMI Prelim (Dec)--
F: --
P: --
Euro Zone ZEW Economic Sentiment Index (Dec)--
F: --
P: --
Germany ZEW Current Conditions Index (Dec)--
F: --
P: --
Germany ZEW Economic Sentiment Index (Dec)--
F: --
P: --
Euro Zone Trade Balance (Not SA) (Oct)--
F: --
P: --
Euro Zone ZEW Current Conditions Index (Dec)--
F: --
P: --
Euro Zone Trade Balance (SA) (Oct)--
F: --
P: --
Euro Zone Total Reserve Assets (Nov)--
F: --
P: --
U.K. Inflation Rate Expectations--
F: --
P: --
U.S. U6 Unemployment Rate (SA) (Nov)--
F: --
P: --
U.S. Unemployment Rate (SA) (Nov)--
F: --
P: --
U.S. Average Hourly Wage MoM (SA) (Nov)--
F: --
P: --
U.S. Average Hourly Wage YoY (Nov)--
F: --
P: --
U.S. Nonfarm Payrolls (SA) (Nov)--
F: --
P: --


No matching data
Latest Views
Latest Views
Trending Topics
Top Columnists
Latest Update
White Label
Data API
Web Plug-ins
Affiliate Program
View All

No data
FORT MYERS, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (“AON” or the “Company”) (OTCQX: AONC), one of the fastest growing community-based oncology practices, announced today that the Company will release its second quarter 2024 financial results on Wednesday, August 14, 2024, prior to market open. The Company will host a conference call and live webcast with the investment community at 8:30 a.m. Eastern Time on the same day.
To access the call through a conference line, dial 1-877-704-4453 or for international callers, 1-201-389-0920. The passcode for the live call is 13748211. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The Access ID for the replay call is 13748211. The replay will be available until Wednesday, August 21, 2024.
The financial results and live webcast will be accessible through the Investor Relations section of the Company's website at investors.aoncology.com.
About American Oncology Network
American Oncology Network (AON) (OTCQX: AONC) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 240 providers practicing across 21 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. Learn more at AONcology.com.
Investor Contact:David Afshar, Chief Financial Officer and Chief Operating OfficerInvestors@AONcology.com
Shares of G-III Apparel Group, Ltd. fell sharply during Thursday's session after the company reported worse-than-expected quarterly sales results.
G-III Apparel Group posted adjusted earnings of 13 cents per share, according to data from Benzinga Pro. The company's quarterly sales came in at $609.747 million, missing market estimates of $616.286 million.
G-III Apparel Group shares dipped 13.4% to $27.12 on Thursday.
Here are some other stocks moving in today’s mid-day session.
Gainers
Losers
Now Read This: Jim Cramer Recommends Buying PNC Financial Services, Calls MasTec A ‘Great Infrastructure Play’
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Health care stocks rose late Tuesday afternoon, with the NYSE Health Care Index adding 0.4% and the Health Care Select Sector SPDR Fund (XLV) increasing 0.1%.
The iShares Biotechnology ETF (IBB) fell 0.6%.
In corporate news, Mangoceuticals said it is developing proprietary oral formulations of semaglutide and tirzepatide to help with weight management. The shares surged 101%.
Biodexa Pharmaceuticals shares surged 88% after it said Tuesday that "positive" and "statistically significant" results from a phase 2 trial of its newly licensed eRapa in familial adenomatous polyposis are scheduled for presentation at the annual meeting of the Digestive Disease Week.
American Oncology Network said that it has decided to delist its class A shares and warrants from Nasdaq, with the last trading day expected on or about June 7. Its shares plunged 35.7%.
Senate Finance Committee Chair Ron Wyden is seeking information on Pfizer's tax practices. In a letter sent Monday to Pfizer Chief Executive Albert Bourla, Wyden asked how Pfizer managed to book most of its profits offshore, despite the US market contributing significantly to its global revenue. Pfizer shares were rising 0.3%.
U.S. stocks traded mostly higher toward the end of trading, with the Dow Jones index gaining around 0.1% on Tuesday.
The Dow traded up 0.07% to 39,835.87 while the NASDAQ rose 0.06% to 16,805.01. The S&P 500 also rose, gaining, 0.12% to 5,314.54 .
Check This Out: These 3 Consumer Stocks With Over 3% Dividend Yields Are Recommended By Wall Street’s Most Accurate Analysts
Leading and Lagging Sectors
Utilities shares rose by 0.6% on Tuesday.
In trading on Tuesday, industrials shares fell by 0.3%.
Top Headline
Macy's Inc reported better-than-expected first-quarter adjusted earnings and raised the outlook.
The company reported a first-quarter FY24 sales decline of 2.7% year-on-year to $4.846 billion, slightly missing the analyst consensus of $4.86 billion. Adjusted EPS of 27 cents beat the analyst consensus of 15 cents.
Macy's updated FY24 sales outlook from $22.2 billion – $22.9 billion to $22.3 billion – $22.9 billion, against the consensus of $22.81 billion. The company raised FY24 adjusted EPS guidance from $2.45 – $2.85 to $2.55 – $2.90 versus the Street view of $2.62.
Equities Trading UP
Equities Trading DOWN
Also Check This Out: Top 5 Defensive Stocks That May Keep You Up At Night In Q2
Commodities
In commodity news, oil traded down 0.8% to $79.20 while gold traded down 0.6% at $2,424.80.
Silver traded down 0.9% to $32.12 on Tuesday, while copper rose 0.8% to $5.1175.
Euro zone
European shares closed lower today. The eurozone's STOXX 600 fell 0.18%, Germany's DAX fell 0.22% and France's CAC 40 dipped 0.66%. Spain's IBEX 35 Index fell 0.04%, while London's FTSE 100 fell 0.09%.
The Eurozone recorded a trade surplus of €24.1 billion in March compared to a €19.1 billion surplus in the year-ago month. The current account surplus in the Eurozone rose to €44.5 billion in March from €27.0 billion in the year-ago period. Construction output in the Eurozone rose 0.1% year-over-year in March.
Producer prices in Germany fell by 3.3% year-over-year in April compared to a 2.9% decline in the prior month.
Asia Pacific Markets
Asian markets closed lower on Tuesday, with Japan's Nikkei falling 0.31%, China's Composite Index declining 0.42%, Hong Kong's Hang Seng Index dipping 2.12% and India's S&P BSE Sensex falling 0.1%.
Economics
No major economic reports will be released today.
Now Read This: How To Earn $500 A Month From Williams-Sonoma Stock Ahead Of Q1 Earnings
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
GT Biopharma said Tuesday it priced a registered direct offering of 740,000 shares at $4.35 per share to raise about $3.2 million for general corporate purposes. It will also issue warrants in a concurrent private placement.
Shares sank about 31%, with intraday trading volume at more than 18.1 million versus a daily average of about 1.06 million.
LuxUrban Hotels said it priced a public offering of 30.5 million shares at $0.25 apiece.
The company intends to use the proceeds for working capital and other general corporate purposes.
Shares slid 42% as intraday trading volume surged to over 9.28 million versus the stock's daily average of about 607,000.
American Oncology Network said that it has decided to delist its Class A common stock and warrants from the Nasdaq Capital Market, with the last trading day expected on or about June 7.
Shares slumped 33% after intraday trading volume climbed to over 247,000 from a daily average of about 13,000.
Shares of James Hardie Industries plc fell sharply during Tuesday's session after the company reported worse-than-expected quarterly financial results.
James Hardie Industries posted adjusted earnings of 40 cents per share, missing market expectations of 42 cents per share. The company's quarterly sales came in at $1.005 billion versus estimates of $1.009 billion, according to data from Benzinga Pro.
JP Morgan analyst Al Harvey downgraded James Hardie Industries from Overweight to Neutral.
James Hardie Industries shares dipped 14.3% to $31.36 on Tuesday.
Here are some other stocks moving in today’s mid-day session.
Gainers
Losers
Now Read This: This Walt Disney Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining around 0.2% on Tuesday.
The Dow traded up 0.19% to 39,883.93 while the NASDAQ rose 0.01% to 16,794.91. The S&P 500 also rose, gaining, 0.12% to 5,314.33 .
Check This Out: These 3 Consumer Stocks With Over 3% Dividend Yields Are Recommended By Wall Street’s Most Accurate Analysts
Leading and Lagging Sectors
Energy shares rose by 0.4% on Tuesday.
In trading on Tuesday, consumer discretionary shares fell by 0.5%.
Top Headline
Lowe's Companies Inc reported better-than-expected first-quarter financial results.
The company reported a first-quarter FY24 sales decline of 4.4% year-on-year to $21.364 billion, beating the analyst consensus estimate of $21.123 billion. EPS of $3.06 beat the analyst consensus estimate of $2.94.
Comparable sales decreased 4.1% due to a decline in DIY big ticket discretionary spending was partially offset by positive comparable sales in Pro and online.
Equities Trading UP
Equities Trading DOWN
Also Check This Out: Top 5 Defensive Stocks That May Keep You Up At Night In Q2
Commodities
In commodity news, oil traded down 0.7% to $79.21 while gold traded down 0.2% at $2,434.50.
Silver traded down 0.2% to $32.355 on Tuesday, while copper rose 1.1% to $5.1325.
Euro zone
European shares were lower today. The eurozone's STOXX 600 fell 0.28%, Germany's DAX fell 0.34% and France's CAC 40 dipped 0.83%. Spain's IBEX 35 Index fell 0.16%, while London's FTSE 100 fell 0.10%.
The Eurozone recorded a trade surplus of €24.1 billion in March compared to a €19.1 billion surplus in the year-ago month. The current account surplus in the Eurozone rose to €44.5 billion in March from €27.0 billion in the year-ago period. Construction output in the Eurozone rose 0.1% year-over-year in March.
Producer prices in Germany fell by 3.3% year-over-year in April compared to a 2.9% decline in the prior month.
Asia Pacific Markets
Asian markets closed lower on Tuesday, with Japan's Nikkei falling 0.31%, China's Composite Index declining 0.42%, Hong Kong's Hang Seng Index dipping 2.12% and India's S&P BSE Sensex falling 0.1%.
Economics
No major economic reports will be released today.
Now Read This: How To Earn $500 A Month From Williams-Sonoma Stock Ahead Of Q1 Earnings
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
White Label
Data API
Web Plug-ins
Poster Maker
Affiliate Program
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.
Not Logged In
Log in to access more features

FastBull Membership
Not yet
Purchase
Log In
Sign Up